稳定患者高危斑块的冠周脂肪密度与18F-氟化钠冠状动脉摄取相关
本研究在冠脉CTA显示高危斑块的稳定患者中,评估病变冠周脂肪组织密度增高与冠状动脉18F-氟化钠PET摄取的关系。41例患者中23例(56%)的51个病变显示18F-氟化钠活性增高;有摄取病变的冠周脂肪密度高于无摄取病变(-73 HU vs -86 HU,p<0.001),且冠周脂肪密度与靶本底比值及SUVmax相关。作者认为同时评估这些影像生物标志物可能改善高危斑块稳定患者的心血管风险预测。
要点
- 高危斑块定义为正性重构、低衰减斑块(<30 HU)伴点状钙化、狭窄≥50%且斑块体积>100 mm3三项并存。
- 有18F-氟化钠摄取的病变冠周脂肪密度高于无摄取病变(-73 HU vs -86 HU,p<0.001)。
- 冠周脂肪密度与18F-氟化钠靶本底比值(r=0.63)及SUVmax(r=0.68)相关(均p<0.001)。
核心结论
- 在冠脉CTA显示高危斑块特征的患者中,冠周脂肪密度增高与局灶性18F-氟化钠PET摄取相关;作者认为同时评估这些影像生物标志物可能改善高危斑块稳定患者的心血管风险预测。
研究设计与样本
- 研究论文;共招募41例患者(年龄65±6岁,68%为男性),经冠脉CTA筛查出高危斑块后行18F-氟化钠PET/CT,对狭窄≥25%的病变进行定量斑块分析、平均冠周脂肪密度及运动校正后18F-氟化钠SUVmax和靶本底比值测量。
关键影像表现/征象
- 有18F-氟化钠摄取的病变周围冠周脂肪密度高于无摄取病变(-73 HU,四分位距-79至-68 HU vs -86 HU,四分位距-94至-80 HU;p<0.001)。
- 高危斑块定义为正性重构、低衰减斑块(<30 HU)和点状钙化三项斑块特征并存,并伴阻塞性冠状动脉狭窄≥50%(斑块体积>100 mm3)。
- 23例患者(56%)的51个病变显示冠状动脉18F-氟化钠活性增高。
诊断标准与关键数值
- 高危斑块定义:正性重构、低衰减斑块(<30 HU)和点状钙化三项斑块特征并存,伴阻塞性冠状动脉狭窄≥50%(斑块体积>100 mm3)。
- 病变纳入定量分析条件:狭窄≥25%。
- 有18F-氟化钠摄取病变的冠周脂肪密度为-73 HU(四分位距-79至-68 HU),无摄取病变为-86 HU(四分位距-94至-80 HU),p<0.001。
- 18F-氟化钠靶本底比值与冠周脂肪密度相关(r=0.63,p<0.001),SUVmax与冠周脂肪密度相关(r=0.68,p<0.001)。
- 校正多元回归分析中,病变冠周脂肪密度增高(β=0.25;95%CI 0.17至0.34;p<0.001)和低衰减斑块体积(β=0.07;95%CI 0.03至0.11;p=0.002)与18F-氟化钠靶本底比值相关。
临床应用与阅片要点
- 作者认为,通过18F-氟化钠PET和CTA同时评估这些影像生物标志物可能改善高危斑块稳定患者的心血管风险预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to assess the association between increased lesion peri-coronary adipose tissue (PCAT) density and coronary 18F-sodium fluoride (18F-NaF) uptake on positron emission tomography (PET) in stable patients with high-risk coronary plaques (HRPs) shown on coronary computed tomography angiography (CTA).
BACKGROUND: Coronary 18F-NaF uptake reflects the rate of calcification of coronary atherosclerotic plaque. Increased PCAT density is associated with vascular inflammation. Currently, the relationship between increased PCAT density and 18F-NaF uptake in stable patients with HRPs on coronary CTA has not been characterized.
METHODS: Patients who underwent coronary CTA were screened for HRP, which was defined by 3 concurrent plaque features: positive remodeling; low attenuation plaque (LAP) (<30 Hounsfield units [HU]) and spotty calcification; and obstructive coronary stenosis ≥50% (plaque volume >100 mm3). Patients with HRPs were recruited to undergo 18F-NaF PET/CT. In lesions with stenosis ≥25%, quantitative plaque analysis, mean PCAT density, maximal coronary motion-corrected 18F-NaF standard uptake values (SUVmax), and target-to-background ratios (TBR) were measured.
RESULTS: Forty-one patients (age 65 ± 6 years; 68% men) were recruited. Fifty-one lesions in 23 patients (56%) showed increased coronary 18F-NaF activity. Lesions with 18F-NaF uptake had higher surrounding PCAT density than those without 18F-NaF uptake (-73 HU; interquartile range -79 to -68 HU vs. -86 HU; interquartile range -94 to -80 HU; p < 0.001). 18F-NaF TBR and SUVmax were correlated with PCAT density (r = 0.63 and r = 0.68, respectively; all p < 0.001). On adjusted multiple regression analysis, increased lesion PCAT density and LAP volume were associated with 18F-NaF TBR (β = 0.25; 95% confidence interval: 0.17 to 0.34; p < 0.001 for PCAT, and β = 0.07; 95% confidence interval: 0.03 to 0.11; p = 0.002 for LAP).
CONCLUSIONS: In patients with HRP features on coronary CTA, increased density of PCAT was associated with focal 18F-NaF PET uptake. Simultaneous assessment of these imaging biomarkers by 18F-NaF PET and CTA might refine cardiovascular risk prediction in stable patients with HRP features.
引用
- Kwiecinski J, Dey D, Cadet S, et al. Peri-Coronary Adipose Tissue Density Is Associated With 18F-Sodium Fluoride Coronary Uptake in Stable Patients With High-Risk Plaques. JACC Cardiovasc Imaging. 2019. PMID: 30772226. doi:10.1016/j.jcmg.2018.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。